Value and Implementation of the Aggregate Safety Assessment Plan Barbara A. HendricksonAnupam AgarwalLothar Tremmel Current Opinion 19 April 2023 Pages: 171 - 181
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials Andriani C. PateraJulie MaidmentKen Twomey Current Opinion Open access 26 April 2023 Pages: 183 - 202
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond Lisa GieberVincent Muturi-KioiAyesha Sitlani Current Opinion 28 April 2023 Pages: 203 - 214
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape Khoi ThanLori Salamida Leading Article 23 April 2023 Pages: 215 - 220
Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions Zhixing YaoWilliam V. McCall Review Article 13 April 2023 Pages: 221 - 232
Black-Box Warnings of Antiseizure Medications: What is Inside the Box? Abdul WahabAttiya Iqbal Review Article 29 April 2023 Pages: 233 - 250
Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities Neil McAuslaneMagda BujarStuart Walker Original Research Article 19 April 2023 Pages: 251 - 260
Major Pharmaceutical Conferences and Courses: August to September 2023 Update 06 April 2023 Pages: 261 - 263